Publication | Closed Access
Effective inhibition of aromatase inhibitor‐associated bone loss by zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole
216
Citations
17
References
2008
Year
At 12 months, immediate zoledronic acid therapy prevented bone loss in postmenopausal women who were receiving adjuvant letrozole.
| Year | Citations | |
|---|---|---|
Page 1
Page 1